Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 134.00 | 98.75 | 1.3570 | 1.4704 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 156.25 | 36.27 | 134.00 | 98.75 | 1.3570 | 1.4704 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 196.00 | 98.75 | 1.9848 | 2.2142 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 133.00 | 98.75 | 1.3468 | 1.4577 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 156.25 | 36.27 | 83.00 | 98.75 | 0.8405 | 0.7734 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 36.27 | 115.00 | 98.75 | 1.1646 | 1.2224 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 103.00 | 98.75 | 1.0430 | 1.0592 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 36.27 | 83.00 | 98.75 | 0.8405 | 0.7734 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 65.00 | 98.75 | 0.6582 | 0.4974 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 59.00 | 98.75 | 0.5975 | 0.4003 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 72.00 | 98.75 | 0.7291 | 0.6072 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 61.00 | 98.75 | 0.6177 | 0.4330 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 156.25 | 36.27 | 59.00 | 98.75 | 0.5975 | 0.4003 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 97.00 | 98.75 | 0.9823 | 0.9754 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 108.00 | 98.75 | 1.0937 | 1.1279 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 108.00 | 98.75 | 1.0937 | 1.1279 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 179.00 | 98.75 | 1.8127 | 2.0186 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 156.25 | 36.27 | 80.00 | 98.75 | 0.8101 | 0.7288 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 119.00 | 98.75 | 1.2051 | 1.2756 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 156.25 | 36.27 | 84.00 | 98.75 | 0.8506 | 0.7882 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 156.25 | 36.27 | 132.00 | 98.75 | 1.3367 | 1.4449 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 156.25 | 36.27 | 140.00 | 98.75 | 1.4177 | 1.5465 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 36.27 | 159.00 | 98.75 | 1.6101 | 1.7809 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 156.25 | 36.27 | 49.00 | 98.75 | 0.4962 | 0.2314 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 156.25 | 36.27 | 94.00 | 98.75 | 0.9519 | 0.9329 |